HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 188 filers reported holding HEALTH CATALYST INC in Q4 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365,970 | +197.5% | 36,163 | +267.4% | 0.00% | +200.0% |
| Q2 2023 | $123,031 | -91.6% | 9,842 | -92.2% | 0.00% | -88.9% |
| Q1 2023 | $1,464,103 | -61.1% | 125,459 | -64.6% | 0.01% | -59.1% |
| Q4 2022 | $3,765,709 | +4.7% | 354,253 | -4.5% | 0.02% | +10.0% |
| Q3 2022 | $3,597,000 | +15.5% | 370,869 | +72.6% | 0.02% | +5.3% |
| Q2 2022 | $3,114,000 | +89.1% | 214,891 | +241.0% | 0.02% | +35.7% |
| Q1 2022 | $1,647,000 | +25.5% | 63,026 | +90.3% | 0.01% | +16.7% |
| Q4 2021 | $1,312,000 | -13.9% | 33,119 | +8.8% | 0.01% | -36.8% |
| Q3 2021 | $1,523,000 | -60.6% | 30,444 | -56.3% | 0.02% | -56.8% |
| Q2 2021 | $3,870,000 | +43.0% | 69,715 | +20.5% | 0.04% | +25.7% |
| Q1 2021 | $2,706,000 | +12.8% | 57,852 | +4.9% | 0.04% | +6.1% |
| Q4 2020 | $2,400,000 | +421.7% | 55,136 | +338.6% | 0.03% | +371.4% |
| Q3 2020 | $460,000 | -62.5% | 12,570 | -70.1% | 0.01% | -66.7% |
| Q2 2020 | $1,227,000 | +2892.7% | 42,073 | +2588.4% | 0.02% | +2000.0% |
| Q1 2020 | $41,000 | – | 1,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 852,504 | $8,269,000 | 11.18% |
| Nepsis Inc. | 826,841 | $8,020,000 | 2.90% |
| First Light Asset Management, LLC | 1,149,833 | $11,153,000 | 1.13% |
| Bullseye Asset Management LLC | 55,434 | $538,000 | 0.31% |
| Portolan Capital Management | 303,602 | $2,945,000 | 0.31% |
| CVS HEALTH Corp | 32,273 | $313,000 | 0.30% |
| Rock Springs Capital Management LP | 880,000 | $8,536,000 | 0.22% |
| Granahan Investment Management | 648,299 | $6,289,000 | 0.20% |
| Bares Capital Management | 452,400 | $4,388,000 | 0.17% |
| Rhenman & Partners Asset Management AB | 180,000 | $1,588,000 | 0.17% |